Recent Updates
Recently added Catalysts
COYA Positive Sentiment

Coya Therapeutics to Present Neurofilament Light Chain (NfL) Biomarker Stratification Methodology in the ALSTARS Trial to Minimize the Impact of Heterogeneity in ALS Clinical Trials at the 2026 Annual NEALS Meeting

Wednesday, October 28, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Coya Therapeutics announced a poster presentation at the 2026 Annual NEALS Meeting, scheduled for October 28th in Clearwater, Florida. The presentation will focus on a Neurofilament Light Chain biomarker stratification methodology aimed at reducing heterogeneity in ALS clinical trials. NEALS is recognized as the largest ALS research consortium globally.

Market Sentiment Analysis

POSITIVE FACTORS

  • Coya will present at a prominent ALS research meeting.
  • The methodology aims to improve clinical trial outcomes.
  • Focus on minimizing heterogeneity in ALS trials.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+40%
120-day peak, hindsight
Typical move
2.4%
average across 3 past catalysts
Cash runway
~15 mo
Low dilution risk
Lead asset
COYA 302
Phase 2 · Amyotrophic Lateral Sclerosis (ALS)

Full Press Release Details

HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, announces a poster presentation at the 2026 Annual NEALS Meeting on October 28th in Clearwater, Florida. NEALS (Network of Excellence for ALS) is the world’s largest ALS research consortium, dedicated to accelerating the development of new treatments for ALS and Motor Neuron Disease (MND). Coya is currently con

Frequently Asked Questions

What is the focus of Coya's presentation at NEALS 2026?

Coya's presentation will focus on a Neurofilament Light Chain biomarker methodology.

When is the NEALS 2026 Meeting scheduled?

The NEALS 2026 Meeting is scheduled for October 28th.

Where will the NEALS 2026 Meeting take place?

The meeting will take place in Clearwater, Florida.

What is NEALS known for?

NEALS is the world's largest ALS research consortium.

ShareAdd on Google
Tags: COYA Coya Therapeutics NfL biomarker ALS clinical trials NEALS
Last updated: Oct 28, 2026

Biotech snapshot

Cash runway
$43M liquidity · $2M/mo burn
~15 mo
Low dilution risk
Lead asset
COYA 302Phase 2
Amyotrophic Lateral Sclerosis (ALS) →

Catalyst track record

+40%
best trade around COYA's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for COYA.

See every catalyst's timing & PoA →